BioSpace News Archive

IDEXX Laboratories, Inc., a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in two upcoming conferences.

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism pioneering therapies for genetically defined diseases, announced that the U.S. Food and Drug Administration has approved PYRUKYND® in the U.S. for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency, a rare, debilitating, lifelong hemolytic anemia.

Aziyo Biologics, Inc., a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced that it plans to release its fourth quarter and full year 2021 earnings results after market close on Thursday, March 3, 2022.

Curis, Inc., a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, announced that the Company will release its fourth quarter 2021 financial results on Thursday, February 24, 2022, after the close of U.S. markets.

T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced financial results for the fourth quarter and full year ended December 31, 2021.

Coherus BioSciences, Inc., reported financial results for the quarter and full year ended December 31, 2021 and highlighted recent achievement of important milestones toward the Company’s key strategic initiatives:

bArtivion, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced its financial results for the fourth quarter and full year ended December 31, 2021.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced updates on its investigational gene therapy programs in clinical development.

CooperCompanies, will present at Oppenheimer’s 32nd Annual Healthcare Conference on Wednesday, March 16, 2022.

NexImmune, Inc. announced that Kristi Jones has been appointed as the Company’s Chief Executive Officer and a member of its Board of Directors.